Over the past few years, a new class of injectable medications has changed the way obesity is treated. Two drugs—tirzepatide and semaglutide—have shown striking results in helping people lose weight ...

The research atmosphere over the last few months has been rife with fear and uncertainty due to countless grant pauses or ...

Much has been learned about GLP-1s over many years, but little is understood about why the degree of response to them varies ...

Successfully treating type 2 diabetes may involve focusing on brain neurons, rather than simply concentrating on obesity or insulin resistance, according to a new study. For several years, researchers ...

We appreciate the feedback on and constructive criticism of the CHAIN trial,1 where, as in all complex projects, there were various challenges, many of which were unforeseen. The result—an overall ...

Metformin may reduce knee pain in overweight patients with osteoarthritis, offering a low-cost alternative to early knee ...

The Rush to Crush Cancer bike ride happens this weekend in Pittsburgh, with proceeds benefiting local cancer research.

A new study suggests that gabapentin, a relatively common anti-seizure/pain medication, is linked to improved survival in patients with glioblastoma (GBM) -- the most common and deadly form of brain ...

The field of medical diagnostics and clinical practice is being transformed by the rapid advancement of deep learning ...

Close collaboration between researchers and clinicians at Mayo is what makes the steps of translation — from discovery to the ...

SB 535 formally paves the way for health care clinics to become 'experimental treatment centers' that can provide drugs still ...

The reductions in NIH funding and staff are happening at a time when colorectal cancer cases have been rising among younger ...